Δευτέρα 30 Απριλίου 2018

ResQPOD ITD Overview

hqdefault-3.jpg

The ResQPOD® impedance threshold device (ITD) is a simple, non-invasive device that delivers intrathoracic pressure regulation (IPR) therapy during basic or advanced life support CPR to improve perfusion. - See more from ZOLL.

from EMS via xlomafota13 on Inoreader https://ift.tt/2jfLkg6
via IFTTT

ResQPOD ITD Overview

hqdefault-3.jpg

The ResQPOD® impedance threshold device (ITD) is a simple, non-invasive device that delivers intrathoracic pressure regulation (IPR) therapy during basic or advanced life support CPR to improve perfusion. - See more from ZOLL.

from EMS via xlomafota13 on Inoreader https://ift.tt/2jfLkg6
via IFTTT

Tracing cell-lineage histories

Tracing cell-lineage histories

Tracing cell-lineage histories, Published online: 30 April 2018; doi:10.1038/s41576-018-0015-0

Three new studies in Nature and Nature Biotechnology report methods for dissecting transcriptomic cell phenotypes and lineage history simultaneously by combining single-cell RNA sequencing (scRNA-seq) with CRISPR-based lineage tracing.

from Genetics via xlomafota13 on Inoreader https://ift.tt/2I4zRy2
via IFTTT

Tracing cell-lineage histories



from Genetics via xlomafota13 on Inoreader https://ift.tt/2HDMsor
via IFTTT

ResQPOD ITD Overview

hqdefault-3.jpg

The ResQPOD® impedance threshold device (ITD) is a simple, non-invasive device that delivers intrathoracic pressure regulation (IPR) therapy during basic or advanced life support CPR to improve perfusion. - See more from ZOLL.

from EMS via xlomafota13 on Inoreader https://ift.tt/2jfLkg6
via IFTTT

ResQPOD ITD Overview

hqdefault-3.jpg

The ResQPOD® impedance threshold device (ITD) is a simple, non-invasive device that delivers intrathoracic pressure regulation (IPR) therapy during basic or advanced life support CPR to improve perfusion. - See more from ZOLL.

from EMS via xlomafota13 on Inoreader https://ift.tt/2jfLkg6
via IFTTT

ELMOD3 , a novel causative gene, associated with human autosomal dominant nonsyndromic and progressive hearing loss

Abstract

Autosomal dominant nonsyndromic hearing loss (ADNSHL) is a highly genetically heterogeneous disorder. Up to date only approximately 37 ADNSHL-causing genes have been identified. The goal of this study was to determine the causative gene in a five-generation Chinese family with ADNSHL. A Chinese family was ascertained. Simultaneously, two affected individuals and one normal hearing control from the family were analyzed by whole exome capture sequencing. To assess the functional effect of the identified variant, in-vitro studies were performed. novel missense variant, c.512A>G (p.His171Arg) in exon 8 of the ELMO domain-containing 3 (ELMOD3) gene, was identified as a causative variant in this family affected by late-onset and progressive ADNSHL. The variant was validated by Sanger sequencing and found to co-segregate with the phenotype within the pedigree and was absent in 500 ethnically matched unrelated normal hearing control subjects. To our knowledge, this is the first report of a family with ADNSHL caused by ELMOD3 mutation. Western blots and immunofluorescence staining demonstrated that p.His171Arg resulted in abnormal expression levels of ELMOD3 and abnormal subcellular localization. Furthermore, the analysis of the stability of the wild-type (WT) and mutant ELMOD3 protein shows that the decay of p.His171Arg is faster than that of the WT, suggesting a shorter halflife of the c.512A > G variant. A novel variant in the ELMOD3 gene, encoding a member of the engulfment and cell motility (ELMO) family of GTPase-activating proteins, was identified for the first time as responsible for ADNSHL.



from Genetics via xlomafota13 on Inoreader https://ift.tt/2vYUzuF
via IFTTT